Grifols (GRFS) Short term Debt (2009 - 2023)
Grifols' (GRFS) quarterly Short term Debt came in at $1.1 billion in Q4 2023, up 849.59% YoY from $116.0 million in Q4 2022, and up 849.59% on a QoQ basis from $116.0 million in Q4 2022.
Grifols (GRFS) Short term Debt (2009 - 2023) Analysis & Trends
Grifols (GRFS) has 15 years of Short term Debt data on file, last reported at $1.1 billion in Q4 2023.
- Quarterly Short term Debt rose 849.59% year-over-year to $1.1 billion in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $1.1 billion (up 849.59% YoY) and the FY2023 annual result came in at $1.1 billion, up 849.59% from the prior year.
- Short term Debt grew to $1.1 billion in Q4 2023, from $116.0 million in the prior quarter.
- In the past five years, Short term Debt ranged from a high of $2.6 billion in Q4 2021 to a low of $116.0 million in Q4 2022.
- A 5-year average of $692.7 million and a median of $386.8 million in 2019 frame the typical range for Short term Debt.
- Annual changes were most pronounced in 2021 — Short term Debt jumped 1973.91% — and 2022, when it plunged 95.53%.
- Tracing GRFS's Short term Debt over 5 years: stood at $399.9 million in 2019, then sank by 68.68% to $125.2 million in 2020, then jumped by 1973.91% to $2.6 billion in 2021, then sank by 95.53% to $116.0 million in 2022, then soared by 849.59% to $1.1 billion in 2023.
- The last three Short term Debt figures came in at $1.1 billion (Q4 2023), $116.0 million (Q4 2022), and $2.6 billion (Q4 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn |
| 10 | Grifols | 5.45 Bn | 4.45 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 1.10 Bn |
| Dec 31, 2022 | 115.98 Mn |
| Dec 31, 2021 | 2.60 Bn |
| Dec 31, 2020 | 125.24 Mn |
| Sep 30, 2020 | 373.69 Mn |
| Mar 31, 2020 | 365.85 Mn |
| Dec 31, 2019 | 399.93 Mn |
| Sep 30, 2019 | 462.26 Mn |
| Dec 31, 2018 | 316.60 Mn |
| Sep 30, 2018 | 287.95 Mn |
| Jun 30, 2018 | 244.77 Mn |
| Mar 31, 2018 | 405.38 Mn |
| Dec 31, 2017 | 182.58 Mn |
| Jun 30, 2017 | 163.35 Mn |
| Dec 31, 2016 | 28.20 Mn |
| Sep 30, 2016 | 248.78 Mn |
| Jun 30, 2016 | 243.09 Mn |
| Mar 31, 2016 | 15.11 Mn |
| Dec 31, 2015 | 287.73 Mn |
| Sep 30, 2015 | 280.02 Mn |